Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 1/20 | 0.45 |
| ▸ | CPA1 | P15085 | 3/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | XIAP | P98170 | 1/20 | 0.39 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8069353 | 0.85 | ITGA4 (0.45) | CPA1SLC1A3SLC1A2SLC1A1MEN1 | |
| SCHEMBL9058449 | 0.84 | MMP8 (0.51) | MMP8SLC1A3SLC1A2SLC1A1METAP2 | |
| SCHEMBL892960 | 0.79 | MMP8 (0.61) | MMP8SLC1A3SLC1A2SLC1A1MEN1 | |
| Nitric Acid SCHEMBL27682850 | 0.77 | ALPI (0.51) | MMP8CPA1ALPIPKMPTGS1 | |
| SCHEMBL8095865 | 0.76 | SLC15A1 (0.46) | CPA1SLC1A3SLC1A2SLC1A1ALPI | |
| SCHEMBL5143568 | 0.76 | MMP8 (0.55) | MMP8SLC1A3SLC1A2SLC1A1MEN1 | |
| SCHEMBL5085947 | 0.76 | MMP8 (0.55) | MMP8SLC1A3SLC1A2SLC1A1METAP2 | |
| SCHEMBL18289538 | 0.76 | MMP8 (0.49) | MMP8CPA1EPHX2PPARG | |
| SCHEMBL18289537 | 0.76 | MMP8 (0.49) | MMP8CPA1EPHX2PPARG | |
| SCHEMBL7420068 | 0.75 | MMP8 (0.54) | MMP8SLC1A3SLC1A2SLC1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030040644-A1 | Synthesis of nitroalcohol diastereomers | PHARM-ECO LABORATORIES, INC. | 2003-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040644-A1 | Synthesis of nitroalcohol diastereomers | ALDH7A1, ADRA1A, ADH1A | MMP8 2117/4885CPA1 932/4885SLC1A3 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.